Evidence map›Paper›PMID 23549155›Full record

ArticlemAbs

A novel in vivo method for isolating antibodies from a phage display library by neuronal retrograde transport selectively yields antibodies against p75(NTR.).

Hiroaki Tani, Jane K Osbourn, Edward H Walker, Robert A Rush, Ian A Ferguson

Open access · goldAbstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Recombinant Antibodies in Basic Neuroscience Research.Current protocols in neuroscience · 2020
    Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Hiroaki TaniDepartment of Human Physiology; Centre for Neuroscience; Flinders University School of Medicine; Adelaide, Australia; Current affiliation: Department of Neurology and Neurological Sciences; Stanford University School of Medicine; Stanford, CA USA.
Jane K OsbournMedImmune Ltd. (Formerly Cambridge Antibody Technology); Cambridge, UK.
Edward H WalkerMedImmune Ltd. (Formerly Cambridge Antibody Technology); Cambridge, UK.
Robert A RushDepartment of Human Physiology; Centre for Neuroscience; Flinders University School of Medicine; Adelaide, Australia.
Ian A FergusonDepartment of Human Physiology; Centre for Neuroscience; Flinders University School of Medicine; Adelaide, Australia.
Institut des Sciences Cognitives Marc Jeannerod · FRRecombinant Antibody Technology (United Kingdom) · GBFlinders University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neurotrophin receptor p75(NTR) is utilized by a variety of pathogens to gain entry into the central nervous system (CNS). We tested if this entry portal might be exploited using a phage display library to isolate internalizing antibodies that target the CNS in vivo. By applying a phage library that expressed human single chain variable fragment (scFv) antibodies on their surface to a transected sciatic nerve, we showed that (1) phage conjugated to anti-p75(NTR) antibody or phage scFv library pre-panned against p75(NTR) are internalized by neurons expressing p75(NTR); (2) subsequent retrograde axonal transport separates internalized phage from the applied phage; and, (3) internalized phage can be recovered from a proximal ligature made on a nerve. This approach resulted in 13-fold increase in the number of phage isolated from the injured nerve compared with the starting population, and isolation of 18 unique internalizing p75(NTR) antibodies that were transported from the peripheral nerve into the spinal cord, through the blood-brain barrier. In addition, antibodies recognizing other potentially internalized antigens were identified through in vivo selection using a fully diverse library. Because p75(NTR) expression is upregulated in motor neurons in response to injury and in disease, the p75(NTR) antibodies may have substantial potential for cell-targeted drug/gene delivery. In addition, this novel selection method provides the potential to generate panels of antibodies that could be used to identify further internalization targets, which could aid drug delivery across the blood-brain barrier.

Indexed as

AnimalsBacteriophagesBlood-Brain BarrierCells, CulturedFemaleHumansMolecular Targeted TherapyMotor NeuronsPeptide LibraryRatsRats, Sprague-DawleyReceptor, Nerve Growth FactorSciatic NerveSingle-Chain AntibodiesSpinal CordVirus InternalizationPeptide LibraryReceptor, Nerve Growth FactorSingle-Chain Antibodiesblood-brain barrierinternalizing antibodiesp75NTRphage displayretrograde transportscFv

Identifiers

PMID23549155
PMCPMC4169038
OpenAlexW1969387243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.